Pharmafile Logo

Promoting trust: Cuttsy+Cuttsy become a PIF Tick accredited agency

Cuttsy+Cuttsy join a host of noteworthy healthcare charities and institutions as one of the first healthcare communications agencies to receive the Patient Information Forum’s seal of approval – the PIF Tick.

Living through the COVID-19 pandemic brought with it many unexpected consequences. Among them was the rise of the ‘digital infodemic’. Society found itself bombarded with a vast range of often conflicting health information, produced by different sources, and frequently released without a formal review process. It was hard to know who and what to trust. Added to this, much of the well-researched and peer-reviewed medical information included in this deluge was not underpinned by the principles of health literacy.

Throughout this time, Cuttsy+Cuttsy proved themselves determined to support and uphold trusted, patient-centric health information, and this determination has been recognised. Cuttsy+Cuttsy join a host of noteworthy healthcare charities and institutions as one of the first healthcare communications agencies to receive the Patient Information Forum’s seal of approval – the PIF Tick. A PIF Tick quality mark is assigned to an organisation whose health information meets ten specific criteria points covering aspects such as design, usability, accessibility and user engagement. Information also undergoes a rigorous, auditable production process, making the PIF Tick an industry-wide symbol that can be trusted by everyone.

PIF sets out 10 criteria for trustworthy health information, many of which align closely to Cuttsy+Cuttsy’s values as an organisaion. Ensuring patients are involved in the process of developing health information is a key element in their work. Cross industry collaboration from healthcare professionals to patients ensures all voices are equally heard and valued. This collective approach also guarantees projects and services meet an ‘identified user need’.

Liz Walder PhD, Content Director at Cuttsy+Cuttsy commented; “It is wonderful to have earned an accreditation that aligns so seamlessly with our values as a company. Perhaps the most rewarding part is in knowing no fundamental shifts in attitudes or processes had to be taken to be recognised with a PIF Tick. Our determination to provide trusted and accessible health information for healthcare professionals through to patients has always been there. But now we have a PIF Tick to guide them to it too”.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.

New Cuttsy+Cuttsy research shows why site support matters more than ever

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...

Cuttsy+Cuttsy becomes employee owned

Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.